BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25147970)

  • 21. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of inactivated quadrivalent influenza vaccine in the 2015/2016 season as assessed in both a test-negative case-control study design and a traditional case-control study design.
    Kimiya T; Shinjoh M; Anzo M; Takahashi H; Sekiguchi S; Sugaya N; Takahashi T
    Eur J Pediatr; 2018 Jul; 177(7):1009-1017. PubMed ID: 29680993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.
    Sullivan SG; Tchetgen Tchetgen EJ; Cowling BJ
    Am J Epidemiol; 2016 Sep; 184(5):345-53. PubMed ID: 27587721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis.
    Feng S; Cowling BJ; Kelly H; Sullivan SG
    Am J Epidemiol; 2018 Feb; 187(2):389-397. PubMed ID: 28641373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies.
    Darvishian M; van den Heuvel ER; Bissielo A; Castilla J; Cohen C; Englund H; Gefenaite G; Huang WT; la Bastide-van Gemert S; Martinez-Baz I; McAnerney JM; Ntshoe GM; Suzuki M; Turner N; Hak E
    Lancet Respir Med; 2017 Mar; 5(3):200-211. PubMed ID: 28189522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.
    Wongsurakiat P; Maranetra KN; Wasi C; Kositanont U; Dejsomritrutai W; Charoenratanakul S
    Chest; 2004 Jun; 125(6):2011-20. PubMed ID: 15189916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan.
    Suzuki M; Yoshimine H; Harada Y; Tsuchiya N; Shimada I; Ariyoshi K; Inoue K
    PLoS One; 2013; 8(1):e52103. PubMed ID: 23326324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
    Tam YH; Ng TWY; Chu DKW; Fang VJ; Cowling BJ; Malik Peiris JS; Ip DKM
    Vaccine; 2018 Oct; 36(41):6117-6123. PubMed ID: 30190121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.
    McGrath LJ; Kshirsagar AV; Cole SR; Wang L; Weber DJ; Stürmer T; Brookhart MA
    Arch Intern Med; 2012 Apr; 172(7):548-54. PubMed ID: 22493462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.
    Orenstein EW; De Serres G; Haber MJ; Shay DK; Bridges CB; Gargiullo P; Orenstein WA
    Int J Epidemiol; 2007 Jun; 36(3):623-31. PubMed ID: 17403908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.
    De Smedt T; Merrall E; Macina D; Perez-Vilar S; Andrews N; Bollaerts K
    PLoS One; 2018; 13(6):e0199180. PubMed ID: 29906276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccine effectiveness among healthcare workers in comparison to hospitalized patients: A 2004-2009 case-test, negative-control, prospective study.
    Vanhems P; Baghdadi Y; Roche S; Bénet T; Regis C; Lina B; Robert O; Voirin N; Ecochard R; Amour S
    Hum Vaccin Immunother; 2016; 12(2):485-90. PubMed ID: 26327520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs.
    Suzuki M; Camacho A; Ariyoshi K
    Epidemiol Infect; 2014 Dec; 142(12):2642-6. PubMed ID: 25372226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of quadrivalent influenza vaccine based on the test-negative control study in children during the 2016-2017 season.
    Ando S
    J Infect Chemother; 2018 Oct; 24(10):782-788. PubMed ID: 29945763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis.
    Morimoto N; Takeishi K
    Vaccine; 2018 Feb; 36(7):949-957. PubMed ID: 29373191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
    Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
    Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination.
    Ferdinands JM; Shay DK
    Clin Infect Dis; 2012 Jan; 54(1):25-32. PubMed ID: 22095567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.
    Fielding JE; Grant KA; Papadakis G; Kelly HA
    BMC Infect Dis; 2011 Jun; 11():170. PubMed ID: 21669006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
    Kwong JC; Buchan SA; Chung H; Campitelli MA; Schwartz KL; Crowcroft NS; Jackson ML; Karnauchow T; Katz K; McGeer AJ; McNally JD; Richardson DC; Richardson SE; Rosella LC; Simor A; Smieja M; Zahariadis G; Campigotto A; Gubbay JB
    Vaccine; 2019 Jul; 37(31):4392-4400. PubMed ID: 31221563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
    Bartoszko JJ; McNamara IF; Aras OAZ; Hylton DA; Zhang YB; Malhotra D; Hyett SL; Morassut RE; Rudziak P; Loeb M
    Vaccine; 2018 Jun; 36(24):3434-3444. PubMed ID: 29724509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.